Comparison of the effect of adding dexmedetomidine and fentanyl to bupivacaine on nausea and vomiting in patients undergoing lower extremity orthopedic surgery with spinal anesthesia: A double-blind randomized clinical trial

authors:

avatar Navid Kalani ORCID , avatar Mohammad Hasan Damshenas , avatar Javad Vagharfard , avatar seyed ebrahim Sadeghi , avatar Naser Hatami ORCID , avatar hasan zabetian , *

Koomesh: Vol.24, issue 3; 313-319
published online: August 01, 2022
article type: Research Article
received: August 02, 2021
accepted: October 01, 2021

how to cite: Kalani N, Damshenas M H, Vagharfard J, Sadeghi S E, Hatami N, et al. Comparison of the effect of adding dexmedetomidine and fentanyl to bupivacaine on nausea and vomiting in patients undergoing lower extremity orthopedic surgery with spinal anesthesia: A double-blind randomized clinical trial. koomesh. 2022;24(3):e152740. 

Abstract

Introduction: Nausea and vomiting after surgery is a relatively common complication that despite advances in prevention and treatment is still the most problematic side effect observed in the recovery room and after surgery. The study aimed to evaluate the effect of adding dexmedetomidine and fentanyl to bupivacaine on nausea and vomiting in patients undergoing orthopedic lower extremity surgery with spinal anesthesia. Materials and Methods: This randomized double-blind clinical trial study was performed on 40 patients aged 18 to 50 years with anesthesia classes (ASA I, II) who were candidates for lower limb orthopedic surgery (femur). Patients were randomly divided into two groups: 1: (12.5 mg bupivacaine (2.5 ccs) and 10 mg fentanyl) and group 2: (12.5 μg bupivacaine and 5 μg dexmedetomidine). At recovery times, 6, 12, and 24 hours after surgery Patients;#39 nausea and vomiting were assessed. Results: The results of the Chi-square test showed that there was a significant difference between the groups of bupivacaine-dexmedetomidine and bupivacaine-fentanyl in terms of nausea and vomiting only 6 hours after surgery (P=0.034). At 6 hours postoperatively, the frequency of nausea and vomiting in patients in the bupivacaine-fentanyl group (50%) was higher than in the bupivacaine-dexmedetomidine group (25%). Conclusion: Although in most minutes of the study, there was no significant difference between the two groups in terms of vomiting nausea, at 6 hours after surgery, there was a significant difference between the bupivacaine-dexmedetomidine and bupivacaine-fentanyl groups in terms of nausea. In addition to its analgesic effects, dexmedetomidine appears to prevent nausea and vomiting in patients after surgery.

References

  • 1.

    Kolettas A, Lazaridis G, Baka S, Mpoukovinas I, Karavasilis V, Kioumis I, et al. Postoperative pain management. J Thorac Dis 2015; 7: S62-72.

  • 2.

    Hines R, Barash PG, Watrous G, O'Connor T. Complications occurring in the post anesthesia care unit: A survey. Anesth Analg 1992; 74: 503-509.

  • 3.

    Crocker JS, Vandam LD. Concerning nausea and vomiting during spinal anesthesia. Anesthesiology 1959; 20: 587-592.

  • 4.

    Bernard CM. Spinal and Epidural anesthesia. In: Barash Clinical Anesthesia. 7th ed. Philadelphia: Lippincott Williams = Wilkins; 2013; P: 905-936.

  • 5.

    Malekshoar M, Jarineshin H, Kalani N, Vatankhah M. Comparing the effect of metoclopramide and promethazine on preventing nausea and vomiting after laparoscopic cholecystectomy: A double-blind clinical trial. Koomesh 2021; 23: 203-210. (Persian).

  • 6.

    Taravati SH, Doroudian MR, Beykzadeh S, Shabani M. Comparison the effects of fentanyl, sufentanil and alfentanil as premedication on post-operative nausea and vomiting in diagnostic gynecologic laparoscopy. Koomesh 2013; 14: 285-291. (Persian).

  • 7.

    Kalani N, Ghasemlo H, Vatankhah M, Rastgarian A, RasekhJahromi A, Taheri L, et al. Control of nausea and vomiting in women under spinal anesthesia: A narrative review study on the role of anesthetics. Iran J Obstet Gynecol Infert 2021: 24. (Pesian).

  • 8.

    Taher-Baneh N, Ghadamie N, Sarshivi F, Sahraie R, Nasseri K. Comparison of fentanyl and dexmedetomidine as an adjuvant to bupivacaine for unilateral spinal anesthesia in lower limb surgery: a randomized trial. Braz J Anesthesiol 2019; 69: 369-376.

  • 9.

    Faiz SH, Rahimzadeh P, Sakhaei M, Imani F, Derakhshan P. Anesthetic effects of adding intrathecal neostigmine or magnesium sulphate to bupivacaine in patients under lower extremities surgeries. J Res Med Sci 2012; 17: 918-922.

  • 10.

    Reuben SS, Buvanendran A. Preventing the development of chronic pain after orthopedic surgery with preventive multimodal analgesic techniques. J Bone Joint Surg Am 2007; 89: 1343-1358.##https://doi.org/10.2106/00004623-200706000-00025.

  • 11.

    Jain N, Mathur PR, Soni P, Patodi V, Sethi SK, Mathur V. A comparative clinical study of intrathecal bupivacaine 2.5 mg with dexmedetomidine 5 g versus intrathecal bupivacaine 2.5 mg with fentanyl 25 g on the duration of labor analgesia using combined spinal epidural technique. J ObstetAnaesth Crit Care. 2019; 9: 24- 29.##https://doi.org/10.4103/joacc.JOACC_21_18.

  • 12.

    Jain N, Mathur PR, Soni P, Patodi V, Sethi SK, Mathur V. A comparative clinical study of intrathecal bupivacaine 2.5 mg with dexmedetomidine 5 g versus intrathecal bupivacaine 2.5 mg with fentanyl 25 g on the duration of labor analgesia using combined spinal epidural technique. J ObstetAnaesth Crit Care 2019; 9: 24-29.

  • 13.

    Rastgarian A, Sadeghi SE, Damshenas MH, Ghanei M, Kalani N, Hemati H, et al. Effects of administration of dexmedetomidine with intrathecal bupivacaine on analgesia after femoral and tibia orthopedic surgery: A double-blind randomized clinical trial study. Koomesh 2020; 22: 678-685. (Persian).

  • 14.

    Sun Y, Lu Y, Huang Y, Jiang H. Is dexmedetomidine superior to midazolam as a pre-medication in children? A meta-analysis of randomized controlled trials. Paediatr Anaesth 2014; 24: 863-874.

  • 15.

    Hoy SM, Keating GM. Dexmedetomidine: a review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation. Drugs 2011; 71: 1481-1501.

  • 16.

    Vagharfard J, Rastgarian A, Rahmanian M, Pourmokhtari M, Damshenas MH, Taban S, et al. The effect of fentanyl addition to bupivacaine on shivering and vomiting nausea in patients undergoing femoral fracture surgery by spinal anesthesia: A double-blind randomized clinical trial. J Jahrom Univ Med Sci 2020; 18: 9-16. (Persian).

  • 17.

    Rahimzadeh P, Faiz SH, Imani F, Derakhshan P, Amniati S. Comparative addition of dexmedetomidine and fentanyl to intrathecal bupivacaine in orthopedic procedure in lower limbs. BMC Anesthesiol 2018; 18: 62.

  • 18.

    Khosravi F, Sharifi M, Jarineshin H. Comparative study of fentanyl vs dexmedetomidine as adjuvants to intrathecal bupivacaine in cesarean section: a randomized, double-blind clinical trial. J Pain Res 2020; 13: 2475.

  • 19.

    Rahimzadeh P, Faiz SH, Imani F, Derakhshan P, Amniati S. Comparative addition of dexmedetomidine and fentanyl to intrathecal bupivacaine in orthopedic procedure in lower limbs. BMC Anesthesiol 2018; 18: 62.

  • 20.

    Singh R, Kundra S, Gupta S, Grewal A, Tewari A. Effect of clonidine and/or fentanyl in combination with intrathecal bupivacaine for lower limb surgery. J Anesthesiol Clin Pharmacol 2015; 31: 485.

  • 21.

    Jarineshin H, Melekshoar M, Vatankhah M. Comparing the effect of Bupivacaine alone and Bupivacaine with two different doses of Fentanyl on Apgar scores of the newborn during cesarean section under spinal anesthesia. J Anesth Pain 2016; 6: 20-28.

  • 22.

    Golmohammadi M, Karami N, Tahmasebi R. Incidence of shivering of during cesarean section in patient under spinal anesthesia with or without fentanyl.. Studi Med Sci 2020; 31: 423-432.

  • 23.

    Mahendru V, Tewari A, Katyal S, Grewal A, Singh MR, Katyal R. A comparison of intrathecal dexmedetomidine, clonidine, and fentanyl as adjuvants to hyperbaric bupivacaine for lower limb surgery: a double blind controlled study. J Anaesthesiol Clin Pharmacol 2013; 29: 496.

  • 24.

    Gan TJ. Postoperative nausea and vomiting--can it be eliminated? JAMA 2002; 287: 1233-1236.

  • 25.

    Liang X, Zhou M, Feng JJ, Wu L, Fang SP, Ge XY, et al. Efficacy of dexmedetomidine on postoperative nausea and vomiting: a meta-analysis of randomized controlled trials. Int J Clin Exp Med 2015; 8: 8450-8471.

  • 26.

    Chen BS, Peng H, Wu SN. Dexmedetomidine, an alpha2-adrenergic agonist, inhibits neuronal delayed rectifier potassium current and sodium current. Br J Anaesth 2009; 103: 244-254.

  • 27.

    Kimura M, Saito S, Obata H. Dexmedetomidine decreases hyperalgesia in neuropathic pain by increasing acetylcholine in the spinal cord. Neurosci Lett 2012; 529: 70-74.

  • 28.

    Lee C, Kim YD, Kim JN. Antihyperalgesic effects of dexmedetomidine on high-dose remifentanil-induced hyperalgesia. Korean J Anesthesiol 2013; 64: 301-307.

  • 29.

    Turgut HC, Arslan M. An overview of treatment options for postoperative nausea and vomiting after laparoscopic surgical procedures. Anaesth Pain Intensive Care 2016; 20: 193-200.

  • 30.

    Bakri MH, Ismail EA, Ibrahim A. Comparison of dexmedetomidine and dexamethasone for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. Korean J Anesthesiol 2015; 68: 254-260.

  • 31.

    Bakan M,Umutoglu T, Topuz U, Uysal H, Bayram M, Kadioglu H, et al. Opioid-free total intravenous anesthesia with propofol, dexmedetomidine and lidocaine infusions for laparoscopic cholecystectomy: a prospective, randomized, double-blinded study. Braz J Anesthesiol 2015; 65: 191-199.

  • 32.

    Abdalla MW, Sahar M, El Sombaty AI, Abdalla NM, Zeedan RB. Propofol dexmedetomidine versus propofol ketamine for anesthesia of endoscopic retrograde cholangiopancreatography (ERCP)(a randomized comparative study). Egy J Anesthesia 2015; 31: 97-105.

  • 33.

    Lahoorpour A, Mahdavi Jafari R. Comparative effect of Dexmedetomidine versus Propofol in reducing postoperative nausea and vomiting in gynecological laparoscopic surgery. Iran J Anesthesiol Crit Care 2017; 2: 29-40. (Persian).##.